Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | GUSB | P08236 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20508261 | 0.88 | RAB9A (0.55) | NPC1RAB9ACYP1A2CYP2D6SMN1; SMN2 | |
| SCHEMBL20508257 | 0.82 | GUSB (0.48) | NPC1RAB9ACYP1A2SMN1; SMN2CYP2C9 | |
| SCHEMBL21801569 | 0.81 | GSK3B (0.54) | QPCTNPC1RAB9ACYP1A2CYP2D6 | |
| SCHEMBL20508270 | 0.78 | PIP4K2A (0.47) | NPC1RAB9ASMN1; SMN2GUSBEGFR | |
| SCHEMBL20508264 | 0.77 | NPC1 (0.61) | NPC1RAB9ACYP1A2SMN1; SMN2CYP2C9 | |
| SCHEMBL21801493 | 0.76 | EGFR (0.58) | QPCTNPC1RAB9ACYP1A2SMN1; SMN2 | |
| SCHEMBL24076799 | 0.75 | GRIN2B (0.52) | L3MBTL1CHEK1TSHR | |
| SCHEMBL21801536 | 0.75 | RAB9A (0.49) | NPC1RAB9ACYP1A2SMN1; SMN2CYP2C9 | |
| SCHEMBL20508319 | 0.74 | NPC1 (0.57) | NPC1RAB9ACYP1A2SMN1; SMN2CYP2C9 | |
| SCHEMBL20508285 | 0.74 | AURKA (0.49) | NPC1RAB9ACYP1A2SMN1; SMN2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | NORTHERN ILLINOIS RESEARCH FOUNDATION (US) | 2021-06-08 | — | — | US | disclosed |
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | NORTHERN ILLINOIS RESEARCH FOUNDATION (US) | 2021-06-08 | — | — | US | disclosed |
| US-20180271098-A1 | OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180271098-A1 | OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS | CMPK1, IPMK, ITPA | QPCT 1388/4885NPC1 4195/4885RAB9A 4196/4885 |
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | CBR3, AOC3, AHR | QPCT 674/4885NPC1 4255/4885RAB9A 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.